| INTRODUCTION
Mucosa-associated lymphoid tissue (MALT) lymphoma is a lymphoma potentially arising from lymphoid tissue at any mucosal site; it originates from post-germinal center B cells of the marginal zone with rearranged and mutated immunoglobulin heavy and light chain genes. [1] [2] [3] The most frequent localization of extranodal MALT lymphoma is the stomach, followed by the lung, orbital, and head and neck, while rarer sites include the intestine, liver, thyroid, and breast.
Patients are managed with a variety of treatments that generally result in good outcome. With the exception of Helicobacter pylori eradication in localized gastric MALT lymphoma, selection of an appropriate treatment can be challenging. [3] [4] [5] [6] For extragastric locations, the use of antibiotic therapy may be useful in some cases of orbital MALT lymphoma (related to
Chlamydia psittaci).
In patients with limited and localized disease, local treatment approaches are useful, and radiotherapy is often a good choice in the interest of organ preservation. 7 Radiotherapy is recommended as the first-line therapy for localized nongastric MALT lymphoma; instead, chemotherapy or combination of different treatments are reserved for patients with advanced disease, as well as for patients with localized disease who has failed to respond to local treatments.
MALT lymphoma usually has good prognosis with a median survival beyond 10 years, but a part of them seems to be more aggressive and has a higher risk of progression or transformation into aggressive ; however, most of these have not been validated in studies with large cohorts of patients and remain controversial. Recently, Theiblemont et al 13 generated a MALT prognostic index from the dataset of the IELSG-19 trial; they identified elevated serum β2-microglobulin levels, the presence of B symptoms (fever, night sweats, and weight loss), and male sex as prognostic factors for recurrence-free survival and overall survival (OS). F-FDG PET/CT, and treatment modality; and follow-up data were collected and analyzed in all patients.
IPI score and LDH level were dichotomized using a cutoff value of 2 and 245, respectively, and tumor stage according to the Ann Arbor interobserver reproducibility. 21, 22 The VOI was manually adjusted to exclude areas of intense physiologic uptake contiguous to the tumor.
TLG was calculated as the sum of the product of MTV of each lesion and its SUVmean.
| Statistical analysis
All statistical analysis was carried out using MedCalc software version 17.1 for Windows (Ostend, Belgium). A P value of <0.05 was considered statistically significant. The descriptive analysis of categorical variables comprised the calculation of simple and relative frequencies.
The numeric variables were described as mean, minimum, and maximum. Univariate logistic regression analysis was performed to assess the relationship between qualitative 18 F-FDG PET/CT ( 18 F-FDG avidity) and the other clinical and pathological parameters. Variables with P < 0.05 in the univariate analysis were further analyzed using multivariate logistic regression analysis to determine which variables were independently associated.
For the entire population, receiver operating characteristic (ROC) curve analysis was used to identify the optimal cutoff point of semiquantitative parameters in the light of which interpret the results of progression-free survival (PFS) ( Table 2) . PFS was calculated from the date of baseline were plotted according to the Kaplan-Meier method, and differences between groups were analyzed by using a two-tailed log-rank test. Abbreviations: AUC, area under curve; CI, confidence interval; CT, computed tomography; MTV, total metabolic tumor volume; PET, positron emission tomography; PFS, progression-free survival; ROC, receiver operating characteristic; Sens, sensibility; Spec, specificity; SUVbsa, standardized uptake value body surface area; SUVbw, standardized uptake value body weight; SUVlbm, standardized uptake value lean body mass; TLG, total lesion glycolysis; ROC, receiver operating characteristic.
Cox regression was used to estimate the hazard ratio (HR) and its confidence interval (CI ), and average TLG was 526 (range, 13-6300) ( Table 1 ).
Comparing the two groups (positive PET/CT and negative PET/CT) in terms of sex, age, presence of B symptoms, LDH level, IPI score, and presence of plasmacytic differentiation, we found no significant differences between them. The detection rate of Moreover, the patients with 18 F-FDG-avid lesions had significantly larger lesions than had the patients with no FDG-avid lesions (average diameter maximum, 3.9 vs 2.5 cm, P < 0.001).
The correlations between tumor size and high Ki-67 with 18 F-FDG avidity were confirmed also in a multivariate regression analysis, not for primary site of disease and stage. PFS and OS rates were 93% and 98%, respectively, while 5-year PFS and OS rates were 62% and 95%, respectively.
In univariate analysis, considering that the cutoff value was obtained by ROC curve, MTV and TLG were significantly correlated with PFS (P = 0.035 and P = 0.001, respectively) but not with OS In multivariate analysis, only tumor stage and extragastric localization of MALT lymphoma confirmed to be independent prognostic factors for both PFS (P = 0.016 and P = 0.016) and OS (P = 0.045) ( Table 4 
| DISCUSSION
Nowadays, it is under debate if MALT lymphoma is an 18 F-FDG-avid disease or not; controversial results in this field are present in literature. It seems that the site of primary localization of disease is the main feature related with metabolic behavior of this lymphoma; in fact, the highest detection rate is reached in pulmonary, 23 head and neck, 16 liver, 24 and breast 25 MALT lymphomas, whereas gastric and ocular MALT localizations show lower detection rate. 16 Also Ki-67 score, a proliferation index, seems to be correlated with 18 F-FDG avidity in both gastric and extragastric MALT lymphomas. 14, 15 Also in this study, we confirmed the evidence that Ki-67 score (using a threshold of 15%) and tumor size are significantly correlated with FDG avidity.
MALT lymphoma usually is lymphoma with optimal prognosis and a median survival beyond 10 years, but a part of them seems to be more aggressive and has a higher risk of relapse or transformation into aggressive NHL subtype, like diffuse large B-cell lymphoma. 8, 13, 26 In literature, many prognostic factors have been studied with conflicting results. Several factors were identified and associated with relapsefree survival, including disease age, presence of B symptoms, LDH level, performance status, and IPI score. 8, 10, 18 When compared with the stomach, all sites of disease except for head and neck were associated with inferior outcome survival. Abbreviations: CI, confidence interval; HR, hazard ratio; IPI, international prognostic index; LDH, lactate dehydrogenase; MTV, metabolic tumor volume; OS, overall survival; PFS, progression-free survival; SUVbsa, standardized uptake value body surface area; SUVbw, standardized uptake value body weight; SUVlbm, standardized uptake value lean body mass; TLG, total lesion glycolysis.
a Variables dichotomized using cutoff values after receiver operating characteristic analysis reported in Table 2. univariate analysis. Despite these encouraging results, the real effectiveness of MTV and TLG in risk stratification and the possibility to combine these parameters with other clinical or imaging parameters should be evaluated in future studies.
Other metabolic baseline 
| CONCLUSION
In conclusion, in our study, we demonstrated that PET/CT qualitative and semiquantitative features did not influence survival outcome and that only tumor stage and primary localization of MALT lymphoma were independent prognostic parameters.
